首页 › 基金 › Crestline Management, L.P. › SANA
Crestline Management, L.P. 对 SANA 的持仓历史
SANA BIOTECHNOLOGY INC · 医疗保健
Crestline Management, L.P. 在 Q3 2026 的 13F 申报中披露持有 SANA(SANA BIOTECHNOLOGY INC)755,736 股,市值约 US$2.2M,约占其申报组合的 7.52%,在其申报持仓中市值排名第 2 位。 Crestline Management, L.P. 最近 13 个申报季度中有 13 个季度披露了 SANA 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Crestline Management, L.P. 对 SANA 的持仓演变
Crestline Management, L.P. 于 Q3 2023 首次披露 SANA 持仓:3,365,624 股(约 US$13.0M)。 该持仓在 Q1 2024 达到峰值 3,365,624 股,市值约 US$33.7M。 在 13 次申报中,Crestline Management, L.P. 0 次增持、8 次减持、4 次保持不变。 最近一期申报(Q3 2026)显示持股 755,736 股、市值约 US$2.2M。 持仓曾出现大幅变动:Q4 2025 减持约 33% (随后一个季度股价下跌 29%)、Q1 2026 减持约 38% (随后一个季度股价上涨 21%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 3.37M | $13.02M | 新进 |
| Q4 2023 | 3.37M | $13.73M | 持有 |
| Q1 2024 | 3.37M | $33.66M | 持有 |
| Q2 2024 | 3.23M | $17.61M | 减持 |
| Q3 2024 | 3.09M | $12.84M | 减持 |
| Q4 2024 | 2.86M | $4.66M | 减持 |
| Q1 2025 | 2.79M | $4.69M | 减持 |
| Q2 2025 | 2.42M | $6.61M | 减持 |
| Q3 2025 | 1.82M | $6.46M | 减持 |
| Q4 2025 | 1.22M | $4.97M | 减持 |
| Q1 2026 | 755.74K | $2.18M | 减持 |
| Q2 2026 | 755.74K | $2.64M | 持有 |
| Q3 2026 | 755.74K | $2.20M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 SANA 与 13F 数据
SANA(SANA BIOTECHNOLOGY INC)属于医疗保健行业。我们追踪的基金中还有 28 只申报持有 SANA,申报仓位最大的包括:Flagship Pioneering, LLC (US$87.3M), RA CAPITAL MANAGEMENT, L.P. (US$65.4M), Alphabet Inc. (US$8.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 SANA 的基金
- Flagship Pioneering, LLC 25.00M 股 · $87.26M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 18.75M 股 · $65.44M · Q2 2026
- Alphabet Inc. 2.81M 股 · $8.21M · Q3 2026
更多关于 Crestline Management, L.P.
常见问题
How long has Crestline Management, L.P. held SANA?
Crestline Management, L.P. has disclosed SANA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Crestline Management, L.P.'s current position in SANA?
As of Q3 2026, Crestline Management, L.P. holds 755.74K shares of SANA (SANA BIOTECHNOLOGY INC), valued at $2.20M, representing 7.52% of its reported portfolio and ranking #2.
Has Crestline Management, L.P. been buying or selling SANA?
In the latest 13F filing (Q3 2026), Crestline Management, L.P. held unchanged its position in SANA. The position peaked in Q1 2024 at 3.37M shares.
Which other funds hold SANA?
Other major institutional holders of SANA include Flagship Pioneering, LLC, RA CAPITAL MANAGEMENT, L.P., Alphabet Inc., among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.